LLY News and Press, Eli Lilly and Company From 05/14/24

2024-05-14 09:53:00 ET It's a truism in the stock market that winners tend to keep winning. For pharmaceutical companies, making good on that axiom requires a lot of hard work to develop new medicines, and to find ways of adding to established markets that are addressable by their existing ...

2024-05-14 07:30:00 ET One of the biggest contributors to growth in the pharmaceutical industry right now is weight-loss medicine. Diabetes and obesity treatments from Novo Nordisk , such as Ozempic, Rybelsus, and Wegovy, are taking the world by storm. Eli Lilly (NYSE: LLY...

2024-05-14 06:52:19 ET Summary The Invesco S&P 500 Momentum ETF has outperformed the S&P 500 since its inception in 2015. Momentum Index investing works, the methodology captures companies experiencing multiple growth years that the market rewards with higher valuations. ...

2024-05-14 06:30:00 ET There are many dividend stocks on the market. Some will eventually cut or suspend their payouts due to company-specific, economic, or broader market issues. Those aren't the kind of dividend stocks that investors will want to own. Instead, income-seekers should try to...

2024-05-13 11:48:17 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript U.S. dialysis volumes expected to rebound in 2024...

2024-05-12 05:43:33 ET Summary Viking Therapeutics' subcutaneously administered version of VK2735 has generated competitive data in the phase 2 trial in obese patients. The oral formulation of VK2735 reported good tolerability that leaves room for exploration of higher doses. ...

2024-05-12 03:45:00 ET Summary Hangzhou Sciwind Biosciences out-licenses South Korean rights for ecnoglutide injection to HK inno.N Corporation for up to $56 million. Beijing's Sino Biological completes its $48 million acquisition of SignalChem Biotech, adding enzyme production ex...

2024-05-11 11:40:20 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

2024-05-11 08:45:00 ET Excellent, magnificent, fantastic! All of these superlatives (and more) describe Eli Lilly 's (NYSE: LLY) performance in recent years as it has delivered market-crushing returns and strong regulatory progress. Though the stock might peak eventually, we aren't ...

2024-05-11 06:58:33 ET Summary Organon, Pfizer, and Bristol Myers all offer yields above 5% and can  compete with most Treasuries, but only Organon is up YTD. Spinoffs often struggle in their initial years, but Organon's partial reversal of its decline since Merck's castoff h...